Critical involvement of IL-12 in IFN-γ induction by calcineurin antagonists in activated human lymphocytes

Journal of Leukocyte Biology

Miriam Wittmann¹  Claudia Killig¹  Manuela Bruder¹  Thomas Werfel¹  Ralf Gutzmer¹ 

[1] Department of Dermatology and Allergology, Hannover Medical School, GermanyDepartment of Dermatology and Allergology, Hannover Medical School, GermanyDepartment of Dermatology and Allergology, Hannover Medical School, Germany

关键词: T cells;    cytokines;    cell activation;    signal transduction;   

DOI  :  10.1189/jlb.0605328

学科分类：生理学

来源: Federation of American Societies for Experimental Biology

【 摘 要 】

Calcineurin antagonists are known as potent immunosuppressants working particularly on T cells by virtue of their capacity to block nuclear factor of activated T cell (NFAT) activation and translocation to the nucleus. In addition to interleukin (IL)-2 suppression, T helper cell type 1 (Th1) as well as Th2 cytokine transcription is blocked by calcineurin antagonists. Here, we show that calcineurin antagonists such as cyclosporin A (CsA) or tacrolimus can markedly enhance the production of interferon-γ (IFN-γ) by human T cells. This increased IFN-γ production is dependent on T cell receptor (TCR) and CD28 signaling as well as on the presence of IL-12. IL-27, which could mimic the effect of IL-12, was however less potent in inducing IFN-γ production in the presence of CsA and TCR stimulation. Other cytokines such as IL-23, IL-18, IL-2, or the Th2-related cytokine IL-4 are not able to support a calcineurin antagonist-dependent up-regulation of IFN-γ. CsA-dependent IFN-γ production is observable in therapeutic concentrations. The effect is independent of IL-10 or IL-4, as addition of these cytokines could not inhibit the CsA-induced IFN-γ production. The effect of calcineurin antagonists is associated with an increased c-fos expression and DNA-binding activity of the transcription factor activated protein-1 but not with increased DNA-binding activity of T-bet. Our study further supports the relevance of known calcineurin activities other than NFAT activation. The presented data may help to explain why concomitant infections (resulting in increased IL-12 expression) under therapy with calcineurin antagonists often have a negative impact on the activity of the underlying disease (e.g., autoimmune disease).

【 授权许可】

Unknown